Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
TetraLogic Pharmaceuticals Corp
TLOGCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.tetralogicpharma.com
ISIN
US88165U1097
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
458 720 USD
Yield for 12 month
0.00 %
1Y
3Y
5Y
10Y
15Y
TLOG
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Address: 343 Phoenixville Pike, Malvern, PA, United States, 19355
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures TLOG
1 year
3 years
5 years
10 years
EBITDA
-21 140 180 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.59 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
1 USD
Revenue TTM
–
Book Value
-1.25 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.01 USD
Diluted Eps TTM
-0.01 USD
Most Recent Quarter
III 2016
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TLOG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TLOG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TLOG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0127
Price Book MRQ
0.4016
Financials TLOG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TLOG
For 52 weeks
0.0001 USD
0.0001 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
1 289 144
200 Day MA
0.0001 USD
Short Ratio
4.39
Shares Short
1 181 400
Short Percent
7.12 %
BeatStart